These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21848174)

  • 1. Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO.
    Bilen O; Loftis L; Teruya J
    J Extra Corpor Technol; 2011 Jun; 43(2):64-9. PubMed ID: 21848174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
    Hayakawa M; Takano K; Kayashima M; Kasahara K; Fukushima H; Matsumoto M
    J Atheroscler Thromb; 2021 Apr; 28(4):396-401. PubMed ID: 33116032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
    Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
    J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation.
    Mazzeffi M; Bathula A; Tabatabai A; Menaker J; Kaczorowski D; Madathil R; Galvagno S; Pasrija C; Rector R; Tanaka K; Herr D
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):882-887. PubMed ID: 32758410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study.
    Panholzer B; Bajorat T; Haneya A; Kowalski D; Juhl D; Rocke A; Shneyder M; Kuta P; Clausnizer H; Junker R; Kowalski A; Tulun A; Al-Suraimi A; Cremer J; Kalbhenn J; Zieger B; Nowak-Göttl U
    Blood Cells Mol Dis; 2021 Mar; 87():102526. PubMed ID: 33338698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation.
    Tamura T; Horiuchi H; Obayashi Y; Fuki M; Imanaka M; Kuroda M; Nishimura S; Amano M; Sakamoto J; Tamaki Y; Enomoto S; Miyake M; Kondo H; Izumi C; Nakagawa Y
    Cardiovasc Interv Ther; 2019 Oct; 34(4):358-363. PubMed ID: 30656612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.
    Kalbhenn J; Schmidt R; Nakamura L; Schelling J; Rosenfelder S; Zieger B
    J Atheroscler Thromb; 2015; 22(3):265-71. PubMed ID: 25186021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature.
    Malfertheiner MV; Pimenta LP; Bahr VV; Millar JE; Obonyo NG; Suen JY; Pellegrino V; Fraser JF
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):45-52. PubMed ID: 29084501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.
    Kalbhenn J; Schlagenhauf A; Rosenfelder S; Schmutz A; Zieger B
    J Heart Lung Transplant; 2018 Aug; 37(8):985-991. PubMed ID: 29650295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit.
    Sun W; Wang S; Chen Z; Zhang J; Li T; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2020 Jul; 44(7):717-726. PubMed ID: 31970795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):147-51. PubMed ID: 10725999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of rFVIIa in intractable hemorrhage in patients on central veno-arterial ECMO].
    Vanhuyse F; Frotscher B; Lecompte T; Maureira P; Villemot JP; Folliguet T; Toussaint-Hacquard M
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):665-9. PubMed ID: 23993217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Treatment of Extracorporeal Membrane Oxygenation Coagulopathy with Recombinant von Willebrand Factor or Lyophilized Platelets.
    Mazzeffi M; Gonzalez-Almada A; Wargowsky R; Ting L; Moskowitz K; Hockstein M; Davison D; Levy JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2023 Apr; 37(4):522-527. PubMed ID: 36690556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
    Kalbhenn J; Wittau N; Schmutz A; Zieger B; Schmidt R
    Perfusion; 2015 Nov; 30(8):675-82. PubMed ID: 25823366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation.
    Thomas J; Kostousov V; Teruya J
    Semin Thromb Hemost; 2018 Feb; 44(1):20-29. PubMed ID: 28898902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of thromboelastography for the diagnosis of von Willebrand disease.
    Regling K; Kakulavarapu S; Thomas R; Hollon W; Chitlur MB
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27714. PubMed ID: 30945453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour heparin-free veno-right ventricular ECMO: an experimental study.
    Koul B; Vesterqvist O; Egberg N; Steen S
    Ann Thorac Surg; 1992 Jun; 53(6):1046-51. PubMed ID: 1596127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
    Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
    Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.